NCT03017755 Scoliosis Survey to Development Treatment Decision Tool
| NCT ID | NCT03017755 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Scoliosis; Adolescence |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2017-04-11 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2017-04-11 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a survey to help understand the influences related to the decision for Adolescent Idiopathic Scoliosis treatment (observation vs. bracing vs. surgery). The investigator then plans to create a decision aid to help families when making a decision about the treatment choice being presented to them.
Eligibility Criteria
Inclusion Criteria: * Subject (and/or parent of subject) who has previously been treated for Adolescent Idiopathic Scoliosis (AIS) Exclusion Criteria: * Age less than or equal to 12 years
Contact & Investigator
Todd A Milbrandt, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT03017755 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, studying Scoliosis; Adolescence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03017755 currently recruiting?
Yes, NCT03017755 is actively recruiting participants. Contact the research team at paulson.damian@mayo.edu for enrollment information.
Where is the NCT03017755 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT03017755 clinical trial?
NCT03017755 is sponsored by Mayo Clinic. The principal investigator is Todd A Milbrandt, MD at Mayo Clinic. The trial plans to enroll 5,000 participants.